Gene: KIAA1755
Official Full Name: KIAA1755provided by HGNC
Gene Summary: Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in axon guidance. Predicted to be active in cytoplasm and plasma membrane. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA00013 | KIAA1755 Knockout cell line (293T) | Human | KIAA1755 | 1:3~1:6 | negative | Online Inquiry |
| KOA06110 | KIAA1755 Knockout cell line (AC16) | Human | KIAA1755 | 1:3-1:4 | negative | Online Inquiry |
| KOA21553 | KIAA1755 Knockout cell line (BEAS-2B) | Human | KIAA1755 | 1:3~1:4 | negative | Online Inquiry |
| KOA36999 | KIAA1755 Knockout cell line (U-2932) | Human | KIAA1755 | 1:2-1:4 | negative | Online Inquiry |
| KOA52406 | KIAA1755 Knockout cell line (TPC-1) | Human | KIAA1755 | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.